Enhances both innate & adaptive immunity and strengthens body’s immune response to viral infections March 5: In a landmark development for the treatment of COVID-19, Themis Medicare Ltd. (Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its antiviral drug […]
The post DCGI approves Themis Medicare’s VIRALEX® for Covid-19 treatment appeared first on Startup Reporter.
Source: Women Entrepreneur
